| pubmed-article:15953128 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15953128 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15953128 | lifeskim:mentions | umls-concept:C0027051 | lld:lifeskim |
| pubmed-article:15953128 | lifeskim:mentions | umls-concept:C0032143 | lld:lifeskim |
| pubmed-article:15953128 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:15953128 | lifeskim:mentions | umls-concept:C1150269 | lld:lifeskim |
| pubmed-article:15953128 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:15953128 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15953128 | pubmed:dateCreated | 2005-6-14 | lld:pubmed |
| pubmed-article:15953128 | pubmed:abstractText | To explore the role of tissue plasminogen activator (tPA) activity and plasminogen activator inhibitor type 1 (PAI-1) in survivors of a first myocardial infarction (MI). Insulin and proinsulin were analysed as potential risk factors. | lld:pubmed |
| pubmed-article:15953128 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15953128 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15953128 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15953128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15953128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15953128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15953128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15953128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15953128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15953128 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15953128 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15953128 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:15953128 | pubmed:issn | 0954-6820 | lld:pubmed |
| pubmed-article:15953128 | pubmed:author | pubmed-author:DinesenBB | lld:pubmed |
| pubmed-article:15953128 | pubmed:author | pubmed-author:EliassonMM | lld:pubmed |
| pubmed-article:15953128 | pubmed:author | pubmed-author:RautioAA | lld:pubmed |
| pubmed-article:15953128 | pubmed:author | pubmed-author:RøderM EME | lld:pubmed |
| pubmed-article:15953128 | pubmed:author | pubmed-author:LundbladDD | lld:pubmed |
| pubmed-article:15953128 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15953128 | pubmed:volume | 258 | lld:pubmed |
| pubmed-article:15953128 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15953128 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15953128 | pubmed:pagination | 13-20 | lld:pubmed |
| pubmed-article:15953128 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:meshHeading | pubmed-meshheading:15953128... | lld:pubmed |
| pubmed-article:15953128 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15953128 | pubmed:articleTitle | Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction. | lld:pubmed |
| pubmed-article:15953128 | pubmed:affiliation | Department of Internal Medicine, Sunderby Hospital, Luleå, Sweden. | lld:pubmed |
| pubmed-article:15953128 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15953128 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
